Edward T Mathers has bought stock on 5 days since Jul 2023

Edward T. Mathers is a prominent venture capital investor and manager who serves as a key decision-maker at New Enterprise Associates 17, L.P. (NEA 17), one of the leading venture capital firms( Through his role as a manager of NEA 17 GP, LLC, the general partner of NEA 17, Mathers holds a 10% beneficial ownership stake in SpyGlass Pharma, Inc. (SGP)( His investment portfolio through NEA 17 demonstrates significant confidence in emerging pharmaceutical ventures, with his entity's holdings in SpyGlass including substantial positions in multiple preferred stock series that converted to common stock ahead of the company's initial public offering in February 2026(

Mathers' involvement with SpyGlass Pharma reflects his strategic investment activity in the biopharmaceutical sector( On February 9, 2026, concurrent with SpyGlass's IPO, NEA 17 converted preferred stock holdings totaling 5,097,538 shares into common stock and subsequently purchased an additional 937,500 common shares at $16 per share, bringing the entity's total common stock position to 6,035,038 shares( This substantial investment underscores Mathers' active role in identifying and supporting promising pharmaceutical companies in their growth and public market transition stages(

Written by Perplexity from public sources.